Gastrointestinal Infection Clinical Trial
Official title:
Telemedicine Evaluation of Immunocompetent Adult Patients With Symptoms Suggestive of Acute Gastrointestinal Infection Compared With Face-to-face Medical Consultation in an Emergency Department: a Randomized Study of Diagnostic Accuracy
Acute gastroenterocolitis (GECA) in healthy adults is a frequent cause of looking for medical care in emergency care units and most cases are aimed at etiology viral infection or food toxin, being generally self-limited with good prognosis and only need for treatment with behavioral measures and use of medications for relief symptomatic. Anamnesis is the main resource for the diagnosis and stratification of GECA severity and is infrequent alterations of physical examination and complementary examinations without association with symptoms of alert. Telemedicine has become a resource that allows easier and faster access to medical evaluation, with low cost and rational use of resources. Virtual emergency care is part of Hospital Israelita Albert Einstein (HIAE) institutional routine and there is a large number of consultations whose final diagnosis was GECA. It is not known whether the accuracy of diagnosis of GECA by telemedicine is not inferior to the diagnosis by face-to-face evaluation, considered the Golden pattern. The aim of the study is compare the diagnostic accuracy of GECA by telemedicine with that of face-to-face care. It is a prospective randomized study with a population of adult patients who sought in person the screening of the Morumbi Emergency Care Unit of HIAE with symptoms suggestive of GECA (diarrhea with or without other symptoms of the digestive tract and infectious). Patients whose screening will be excluded of nursing directed for immediate evaluation in the emergency room and patients with dysfunctions organisms or immunosuppression. Patients who accept and sign the informed consent form will be randomized into 2 groups: A) immediate face-to-face evaluation; B) evaluation initially by telemedicine and sequentially at face-to-face evaluation. In both cases, the ICD diagnostics will be compiled and grouped according to clinical significance and will be the primary outcome of the study. Service time, exams requested, guidelines, prescription and destination will also be analyzed. Patients and doctors who undergoing group B assessment will be blinded to the telemedicine assessment data.
Status | Not yet recruiting |
Enrollment | 100 |
Est. completion date | December 2022 |
Est. primary completion date | December 2022 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 65 Years |
Eligibility | Inclusion Criteria: - Age> 18 years - Symptoms present less than 7 days. - Without the use of antibiotics in last 30 days prior to the onset of symptoms. - No trips abroad in the last 15 days prior to the onset of symptoms. - Presence of more than three episodes of watery diarrhea in the last 24 hours with or without symptoms related to the infection (fever 38oC, chills, sweating, myalgia, vomiting) that motivated / were looking for the Emergency Care Unit - Signature of informed consent form Exclusion Criteria: - Return to the Emergency Care Unit due to maintenance or aggravation of the complaint - Age> 65 years - Diagnosis of chronic gastrointestinal diseases, gastritis with or without gastroesophageal reflux disease, previous diverticulitis, previous abdominal surgery, chronic colitis, inflammatory bowel diseases, food intolerances (gluten, lactose) - Previous diagnosis of congestive heart failure, HIV / AIDS, active cancer, type I diabetes mellitus, use of any immunosuppressant - Diarrhea chronic - Patient with emergency room criteria by the nursing evaluation of the triage. |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Hospital Israelita Albert Einstein |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Accuracy of telemedicine diagnosis of adult patients with symptoms compatible with acute gastrointestinal infection | The patient will be evaluated by telemedicine and / or face-to-face consultation and at the end will receive the diagnosis, which will be assigned the ICD code. At the end, these ICDs will be grouped by the same clinical significance and will be compared between the two consultation methods (telemedicine versus face-to-face consultation). | through study completion, an average of 1 year | |
Secondary | Time of medical care | Comparison of time (minutes) of medical care between telemedicine and face-to-face consultation. | through study completion, an average of 1 year | |
Secondary | Rate of indication for complementary exams | Comparison of rate (porcentage) of indication for complementary exams between telemedicine and face-to-face consultation. | through study completion, an average of 1 year | |
Secondary | Types of requested exams | Comparison of types of requested exams (porcentage) between telemedicine and face-to-face consultation. | through study completion, an average of 1 year | |
Secondary | Guidelines follow-up | Comparison of guidelines follow-up (porcentage) between telemedicine and face-to-face consultation. | through study completion, an average of 1 year | |
Secondary | Medical prescription | Comparison of medical prescription after completion of the service between telemedicine and face-to-face consultation. | through study completion, an average of 1 year | |
Secondary | Proposed destination after completion of the service | Comparison of proposed destination (percentage of discharge or hospitalization) after completion of the service between telemedicine and face-to-face consultation. | through study completion, an average of 1 year |
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT05484102 -
Preventive Effect of Cow's Milk Fermented With Lactobacillus Paracasei CBA L74 on Common Infectious Diseases in Children
|
N/A | |
Enrolling by invitation |
NCT03299283 -
Specimen Collection and Transport Workflow Evaluations for CLIA-waived Molecular Testing
|
||
Completed |
NCT04239521 -
The Epidemiology, Management, and the Associated Burden of Related Conditions in Alopecia Areata
|
||
Active, not recruiting |
NCT04258059 -
Wells and Enteric Disease Transmission Trial (WET - Trial)
|
N/A | |
Enrolling by invitation |
NCT04501380 -
Efficacy of AEMCOLO (Rifamycin SV MMX) in the Treatment of Small Intestinal Bacterial Overgrowth (SIBO)
|
Phase 2 | |
Recruiting |
NCT04826991 -
Wells and Enteric Disease Transmission
|
N/A | |
Completed |
NCT03454009 -
Kent State University / Price Chopper Employee Wellness Study
|
N/A | |
Enrolling by invitation |
NCT05051358 -
Therapeutic Endoscopic Ultrasound for Gastrointestinal Disorders: A Multicenter Registry Study
|
||
Enrolling by invitation |
NCT05977868 -
Comparing Oral Versus Parenteral Antimicrobial Therapy
|
Phase 4 | |
Recruiting |
NCT03342547 -
Identification of Host Factors of Norovirus Infections in Mini-Gut Model
|
N/A |